Metabolic patterns and biotransformation activities of resveratrol in human glioblastoma cells: relevance with therapeutic efficacies.
Metabolic patterns and biotransformation activities of resveratrol in human glioblastoma cells: relevance with therapeutic efficacies.
复制标题
人胶质母细胞瘤细胞中白藜芦醇的代谢模式和生物转化活性:与治疗效果的相关性
DOI:
10.1371/journal.pone.0027484
复制
发表时间:
2011
期刊:
影响因子:
3.7
通讯作者:
Liu J
中科院分区:
文献类型:
--
作者:
Shu XH;Li H;Sun XX;Wang Q;Sun Z;Wu ML;Chen XY;Li C;Kong QY;Liu J
Background Trans-resveratrol rather than its biotransformed monosulfate metabolite exerts anti-medulloblastoma effects by suppressing STAT3 activation. Nevertheless, its effects on human glioblastoma cells are variable due to certain unknown reason(s). Methodology/Principal Findings Citing resveratrol-sensitive UW228-3 medulloblastoma cell line and primarily cultured rat brain cells/PBCs as controls, the effect of resveratrol on LN-18 human glioblastoma cells and its relevance with metabolic pattern(s), brain-associated sulfotransferase/SULT expression and the statuses of STAT3 signaling and protein inhibitor of activated STAT3 (PIAS3) were elucidated by multiple experimental approaches. Meanwhile, the expression patterns of three SULTs (SULT1A1, 1C2 and 4A1) in human glioblastoma tumors were profiled immunohistochemically. The results revealed that 100 µM resveratrol-treated LN-18 generated the same metabolites as UW228-3 cells, while additional metabolite in molecular weight of 403.0992 in negative ion mode was found in PBCs. Neither growth arrest nor apoptosis was found in resveratrol-treated LN-18 and PBC cells. Upon resveratrol treatment, the levels of SULT1A1, 1C2 and 4A1 expression in LN-18 cells were more up-regulated than that expressed in UW228-3 cells and close to the levels in PBCs. Immunohistochemical staining showed that 42.0%, 27.1% and 19.6% of 149 glioblastoma cases produced similar SULT1A1, 1C2 and 4A1 levels as that of tumor-surrounding tissues. Unlike the situation in UW228-3 cells, STAT3 signaling remained activated and its protein inhibitor PIAS3 was restricted in the cytosol of resveratrol-treated LN-18 cells. No nuclear translocation of STAT3 and PIAS3 was observed in resveratrol-treated PBCs. Treatment with STAT3 chemical inhibitor, AG490, committed majority of LN-18 and UW228-3 cells but not PBCs to apoptosis within 48 hours. Conclusions/Significance LN-18 glioblastoma cells are insensitive to resveratrol due to the more inducible brain-associated SULT expression, insufficiency of resveratrol to suppress activated STAT3 signaling and the lack of PIAS3 nuclear translocation. The findings from PBCs suggest that an effective anticancer dose of resveratrol exerts little side effect on normal brain cells.
登录
查看更多内容
影响因子:
4.8
作者:
Ogata, Yoshitaka;Osaki, Tadashi;Kawase, Ichiro
通讯作者:
Kawase, Ichiro
DOI:
10.3322/caac.20069
发表时间:
2010-05
期刊:
CA: a cancer journal for clinicians
影响因子:
--
作者:
Van Meir EG;Hadjipanayis CG;Norden AD;Shu HK;Wen PY;Olson JJ
通讯作者:
Olson JJ
影响因子:
3.7
作者:
Ganapathy S;Chen Q;Singh KP;Shankar S;Srivastava RK
通讯作者:
Srivastava RK
DOI:
10.1158/1078-0432.ccr-08-0618
发表时间:
2008-08-01
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
Brantley EC;Nabors LB;Gillespie GY;Choi YH;Palmer CA;Harrison K;Roarty K;Benveniste EN
通讯作者:
Benveniste EN
影响因子:
3.9
作者:
Salman, Emily D.;Kadlubar, Susan A.;Falany, Charles N.
通讯作者:
Falany, Charles N.